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Fetal serum b2-microglobulin predicts postnatal renal function spectrum of outcomes ranging from perinatal death with
in bilateral uropathies. terminal renal failure, an absence of amniotic fluid and
Background. Predicting postnatal renal function is crucial pulmonary hypoplasia, to survival with normal renalfor the prenatal evaluation of fetal bilateral uropathies. Prena-
function. In utero, the most severe cases can be readilytal ultrasound can identify intrauterine terminal renal failure,
identified, based on severe oligohydramnios or sono-but is not sensitive enough to identify those infants who would
survive with an impaired renal function. Because it reflects graphic evidence of bilateral renal dysplasia with cystic
fetal glomerular filtration, fetal serum b2-microglobulin is a hyperechogenic kidneys [1–5]. For less severely affected
potential predictor of postnatal renal function. patients, the long-term outcome is difficult to predictMethods. Fetal serum b2-microglobulin (b2m) was assayed
and fetal urinalysis seems more sensitive than ultrasoundin 61 cases of bilateral or low obstructive uropathy, 74 controls,
in identifying fetuses at risk for renal insufficiency [6, 7].and 17 cases of bilateral renal agenesis, and was correlated
with renal function. In the fetus, serum creatinine cannot be used as a
Results. Fetal serum b2m was 3.2 mg/L (range 1.5 to 4.7) in marker of renal function because it crosses the placenta
controls (N 5 74), 9.5 mg/L (range 6.7 to 11.3) in bilateral
and is cleared by the mother. This is not the case forrenal agenesis (N 5 17), 7 mg/L (5.1 to 10.6) in uropathy in
b2-microglobulin (b2m), which has been proposed as awhich terminal renal failure resulted in termination of preg-
nancy (N 5 26), and 3.7 mg/L (range 2.3 to 11.2) in live borns marker for fetal renal function [8]. However, data on
with uropathy (N 5 35). In the latter subgroup, fetal serum the prediction of postnatal morbidity based on fetal se-
b2m was significantly and positively correlated (r 2 5 0.91) with rum b2m levels remain scarce. Indeed, the number ofpostnatal serum creatinine. All survivors with a postnatal serum
fetuses investigated thus far is small and the study popu-creatinine #50 mmol/L had a fetal serum b2m lower than 5
lation heterogeneous, comprising both unilateral and bi-mg/L. Four of 6 survivors with a postnatal serum creatinine
.50 mmol/L had a fetal serum b2m greater than 5 mg/L. lateral uropathies and nephropathies [8–10].
Conclusion. Fetal serum b2-microglobulin is a marker for Our aim was to evaluate the potential of fetal serum
renal function and predicts postnatal serum creatinine in bilat- b2m for the prediction of postnatal serum creatinine ateral or low fetal obstructive uropathy.
six months to three years in a larger population of chil-
dren with a prenatal diagnosis of bilateral obstructive
uropathy.
Fetal obstructive uropathies are among the most fre-
quent anomalies diagnosed by prenatal ultrasound. Their
management is based on the evaluation of renal function. METHODS
While the prognosis is almost universally good in unilat- Patients
eral cases, bilateral uropathies are associated with a wide
Between 1992 and 1998, 152 aliquots of fetal serum
were assayed for b2m. In 61 fetuses with isolated bilateral
obstructive uropathy, fetal blood had been sampled forKey words: fetal renal function, prenatal diagnosis, obstructive uropa-
thy, urethral valves, infant urine, neonate blood. karyotyping and the fetal karyotype was subsequently
found to be normal. In 17 fetuses with bilateral renalReceived for publication September 28, 1999
agenesis, fetal blood was sampled immediately beforeand in revised form January 13, 2000
Accepted for publication February 4, 2000 termination of pregnancy. The 74 remaining cases were
considered as controls. These patients underwent fetalÓ 2000 by the International Society of Nephrology
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blood sampling at 19 to 40 weeks (median 28 weeks) for radioimmunoassay (Pharmacia Diagnostics, Uppsala,
Sweden).a variety of indications, but were eventually found to be
free of the abnormality tested: maternal toxoplasmosis
(51 cases), genetic disease (1 case of Galloway syndrome),
RESULTS
feto-maternal alloimmunization (1 case), karyotyping for
All 17 pregnancies with bilateral fetal renal agenesismild cerebral ventriculomegaly (6 cases), for congenital
were terminated, and the diagnosis was confirmed atheart defect (5 cases), for oligohydramnios related to
autopsy. Among the 61 cases with a bilateral obstructivepremature rupture of membranes (9 cases), or for poly-
uropathy, there were 26 terminations of pregnancy forhydramnios (1 case).
severe oligohydramnios and/or sonographic evidence ofThese 152 samples originated from a variety of fetal
bilateral renal dysplasia. Severe bilateral renal dysplasiamedicine centers: Hoˆpital Necker (N 5 49), Hoˆpital de
was confirmed in the 25 cases in which the parents con-Lausanne (N 5 41), Hoˆpital Robert Debre´ (N 5 18),
sented to postmortem examination. Of the 35 live bornHoˆpital Notre-Dame-de-Bon-Secours (N 5 5; 3 of these
infants, one died at day 3 from acute respiratory distresscases were also included in the pilot study of Berry et
unrelated to his renal condition (premature delivery atal. [8]), CHU Dijon (N 5 4), CHU de Tours (N 5 4)
32 weeks), and 34 survived the neonatal period. Of theCH de Schiltigheim (N 5 3), and other centers (N 5 28).
34 survivors, 28 had a serum creatinine #50 mmol/LIn accordance with French law, termination of preg-
between six months and three years and were symptom-nancy was performed at the parents’ request in cases
free. Six children had a serum creatinine .50 mmol/L.with severe oligohydramnios, bilateral renal dysplasia
One of them died at day 10 due to severe renal failure(hyperechogenic kidneys and/or cortical cysts), or both.
(last serum creatinine at 500 mmol/L). Prenatal sono-Conservative management was offered in the other
graphic findings at the time of fetal blood sampling andcases. Fetal serum b2m values were not taken into ac- postnatal diagnosis are summarized in Table 1.count in deciding perinatal management.
Fetal serum b2m values are presented in Figure 1. InBased on prenatal ultrasonography, the level of the
the control group, fetal serum b2m was independent ofobstruction was evaluated as follows: (a) high-level when
gestational age, with a mean of 3.1 mg/L (SEM 0.06the renal pelvises only were dilated; (b) mid-level when
mg/L; median 3.2 mg/L; range 1.5 to 4.7 mg/L). It wasthe ureters were also dilated; (c) low-level when the
significantly higher in cases with bilateral renal agenesisbladder was involved. The amount of amniotic fluid was
(mean 9.5 mg/L; SEM 0.3 mg/L; median 9.5 mg/L; range
recorded at the time of prenatal diagnosis and subjec-
6.7 to 11.3 mg/L) and in the 26 terminations of pregnancy
tively assessed as severe oligohydramnios (amniotic fluid
for bilateral uropathy with terminal renal failure due to
index lower than 2 cm), moderate oligohydramnios, or
severe dysplasia (mean 7.3 mg/L; SEM 0.33 mg/L, me-
normal amniotic fluid volume. The renal parenchyma
dian 7 mg/L, range 5.1 to 10.6 mg/L). In the 34 survivors,
was described in terms of the presence of cortical cysts the mean for fetal serum b2m was 4.04 mg/L (SEM 0.3or hyperechogenic parenchyma, as opposed to normal mg/L; median 3.7 mg/L; range 2.3 to 11.2 mg/L). In this
parenchyma with cortical-medullary differentiation. The subgroup, fetal serum b2m was positively correlated (r 2 5thickness of the parenchyma was also recorded (paren- 0.91) with serum creatinine sampled between six months
chyma considered thinned if ,3 mm). and three years (Fig. 2).
The outcome of pregnancy was known in all cases. In All 28 fetuses who had a postnatal serum creatinine
case of termination of pregnancy or neonatal death, the
#50 mmol/L at six months to three years had a prenatal
prenatal diagnosis was confirmed by postmortem exami- serum b2m lower than 5 mg/L (specificity 100%). Fournation when the parents consented to it. For survivors, of six babies with bilateral uropathy who survived with
renal function was evaluated postnatally based on serum a postnatal serum creatinine .50 mmol/L had a prenatal
creatinine. All children underwent serial creatinine mea- serum b2m above 5 mg/L (sensitivity 67%). Prenatal and
surements. The last measurement, performed distant postnatal findings of these six cases are summarized in
from any acute complication such as urinary infection, Table 2. The positive predictive value was 100% and the
was taken into account for analysis. Children with serum negative predictive value 93%.
creatinine #50 mmol/L (#5.6 mg/L) were considered to
have normal renal function. This threshold represents
DISCUSSION2 SD above the mean in healthy children [11, 12]. The
height and weight of all children whose creatinine was We report the first series, to our knowledge, in which
#50 mmol/L were within their respective normal ranges. a positive correlation is established between fetal serum
In addition, none of these children had any clinical symp- b2m and postnatal creatinine. This suggests that fetal
tom related to renal failure. serum b2m may predict postnatal glomerular function,
confirming the hypothesis pioneered by Berry et al. [8].Fetal serum b2m was measured using a competitive
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Table 1. Prenatal ultrasound findings and postnatal diagnosis in 61 cases of bilateral or low obstructive uropathy
Termination Neonatal death (N 5 1) or survival Survival with postnatal
of pregnancy with serum creatinine .50 mmol/L serum creatinine #50 mmol/L
N 5 26 (N 5 6) N 5 28
Prenatal sonography
Level of obstruction
Low 23 3 13
Mid 2 1 1 1 8
High 1 2 7
Amniotic fluid volume
Normal 3a 2 24
Oligohydramnios 3 1 3
Severe oligohydramnios 20 1 1 3 1b
Renal parenchyma
Normal 0 2 22
Thin 5e 2 3
Hyperechogenic6cortical cysts 10 1 1 2 3c
Not seenf 2 0 0
Postnatal diagnosis
Posterior urethral valves 18 3 10d
Urethral atresia 2 0 0
Stenosis of the urethral meatus 2 0 0
Obstructive ureterocele 1 0 2
Prune belly 1 0 0
Megaureter 0 1 6
Ureteropelvic junction 1 1 1 2 7
Bilateral duplication 0 0 1
Bilateral reflux 0 0 2
No postmortem examination 1 0 0
a Two cases with hyperechogenic kidneys and cortical cysts; renal dysplasia confirmed postmortem. One case in which severe oligohydramnios occurred in the
third trimester but amniotic fluid volume was normal at the time of blood sampling.
b Severe oligohydramnios resolved after uro-amniotic shunting performed at 26 weeks. No other patient in this series underwent shunting.
c In 2 cases, the amniotic fluid volume was normal and renal hyperechogenicity was moderate without cortical cysts. In one patient, moderate hyperechogenicity
was associated with severe oligohydramnios and resolved after vesico-amniotic shunting (same patient as in b).
d Three of these had urinary ascites.
e All 5 cases associated with severe oligohydramnios.
f Renal parenchyma was not visualized due to severe oligohydramnios.
Fig. 1. Normal and pathologic prenatal fetal serum b2-microglobulin
(mg/L). A, controls (67 cases); B, bilateral kidney agenesis (18 cases);
C, termination of pregnancy due to bilateral renal dysplasia (26 cases); Fig. 2. Fetal serum b2-microglobulin (mg/L) as a function of postnatal
serum creatinine (between 6 months and 3 years) in the 34 cases ofD, infants with postnatal serum creatinine .50 mmol/L (6 cases); E,
infants with postnatal serum creatinine #50 mmol/L (28 cases). live infants.
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We used serum creatinine as a single end point to
assess postnatal glomerular function. While this has the
advantage of being simple and minimally invasive, it is
not entirely satisfactory. Serum creatinine may increase
as a result of complications such as urinary infection.
This is why creatinine measurements were performed
and analyzed distant from any acute problem. We are also
aware that our follow-up is relatively short, but longer
than that of other prenatal series published thus far.
The evaluation of renal function is central to the prog-
nostic evaluation of fetal uropathies once associated mal-
formations have been ruled out. In the fetus, serum creat-
inine cannot be used as a marker of renal function
because it crosses the placenta and is cleared by the
mother [13]. This is not the case for b2m. This protein
is the light chain of the class 1 major histocompatibility
antigens, a 100 amino acid protein with a molecular
weight of 11,800 daltons. Fetal serum b2m is a potential
marker for fetal glomerular function because it is com-
pletely filtered by the glomeruli and reabsorbed and ca-
tebolized by the tubular cells [14]. Therefore, a low glo-
merular filtration rate is expected to decrease the
catabolism of b2m, and in turn would increase its concen-
tration in fetal blood [13, 15]. Fetal serum b2m has three
theoretical advantages over fetal urinalysis: (i) it reflects
glomerular function whereas urinary sodium and b2m
increase as a result of tubular damage; (ii) it is indepen-
dent of gestational age [8–10]; and (iii) it could avoid
misinterpretation of urine samples from one fetal pelvis
in cases of asymmetrical renal involvement.
From a clinical point of view, the potential value of this
new fetal biochemical marker of renal function should,
however, be assessed in comparison with existing meth-
ods. Indeed, in the mildest cases and in the most severe
forms of fetal uropathy, sonography alone is a good
predictor of outcome, and invasive approaches based on
fetal blood or fetal urine biochemistry do not contribute
to the analysis. For instance, in cases with unilateral renal
involvement with a strictly normal contralateral kidney,
normal postnatal renal function can be anticipated based
on sonography alone. At the other end of the spectrum,
fetal renal failure can be diagnosed based on severe
oligohydramnios or sonographic evidence of major bilat-
eral renal dysplasia. Our results, as well as previous stud-
ies, suggest that in such cases the clinical impact of fetal
biochemistry is limited to the confirmation of a poor
prognosis [8–10].
In contrast, in bilateral uropathies with normal amni-
otic fluid volume or moderate oligohydramnios, and
without major structural anomaly of the renal paren-
chyma, neonatal survival is expected, but postnatal mor-
bidity is difficult to predict by sonography alone [6, 16,
17]. To date, fetal serum b2m studies have been reported
in only eight cases of survivors with a bilateral uropathy.
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Fetal serum b2m levels were higher in the most severe
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renal function in children with bilateral obstructive uropathies.cases, but could not be correlated with a quantitative
Obstet Gynecol 82:813–820, 1993
assessment of postnatal renal function in survivors 7. Muller F, Dommergues M, Bussie`res L, Lortat-Jacob SA,
[8, 10]. To our knowledge for the first time, we have Loirat C, Oury JF, Aigrain Y, Niaudet P, Aegerter P, Dumez
Y: Development of human renal function: Reference intervals forestablished that fetal serum b2m was positively correlated
10 biochemical markers in fetal urine. Clin Chem 42:1855–1860,with postnatal serum creatinine in children with bilateral 1996
uropathies. However, we are aware that the postnatal 8. Berry SM, Lecolier B, Smith RS, Bercau G, Dombrowski MP,
Puder KS, Kithier K, Bidat L, Johnson MP, Cotton DB: Pre-follow-up of this cohort should be prolonged over several
dictive value of serum b2-microglobulin for neonatal renal function.years to ascertain whether renal function remains satis- Lancet 345:1277–1278, 1995
factory in the children who survived with normal serum 9. Cobet G, Gummelt T, Bollmann R, Tennstedt C, Brux B: As-
sessment of serum levels of a-1-microglobulin, b-2-microglobulin,creatinine at six months to three years.
and retinol binding protein in the fetal blood. A method for prena-Available data are not sufficient to compare fetal se-
tal evaluation of renal function. Prenat Diagn 16:299–305, 1996
rum b2m with fetal urinalysis for the prenatal prediction 10. Tassis BMG, Trespidi L, Tirelli A, Pace E, Boschetto C, Nicol-
ini U: Serum b2-microglobulin in fetuses with urinary tract anoma-of renal function [6, 7, 16, 18–25]. However, in our experi-
lies. Am J Obstet Gynecol 176:54–57, 1997ence of prenatal prediction of postnatal serum creatinine
11. Donkerwolke RA, Sander PC, Van Steckelenburg GJ, Stoop
above 50 mmol/L at one year, fetal serum b2m over 5 JW, Tiddens HA: Serum creatinine values in healthy children.
Acta Pediatr Scand 59:399–402, 1970mg/L seems to be less sensitive (66%) but more specific
12. Fedman H, Guignard JP: Plasma creatinine in the first months(100%) than the prenatal urine b2m over 2 mg/L (83%
of life. Arch Dis Child 57:123–126, 1982
specific and 80% sensitive) we previously observed [6]. 13. Nolte S, Mueller B, Pringsheim W: Serum alpha 1-microglobulin
In conclusion, we demonstrate a correlation between and b2-microglobulin for the estimation of fetal glomerular renal
function. Pediatr Nephrol 5:473–577, 1991fetal serum b2m and postnatal serum creatinine in 34
14. Revillard JP, Vincent C: Structure and metabolism of beta-2-infants with bilateral uropathy who survived to the age microglobulin. Contrib Nephrol 62:44–53, 1988
of six months. Although in many instances sonography 15. Schardijn GHS, Statius van Eps LW: b2-Microglobulin: Its sig-
nificance in the evaluation of renal function. Kidney Int 32:635–641,alone is sufficient to establish the prognosis of fetal uro-
1987pathy, we believe that in selected cases invasive testing
16. Glick PL, Harrisson MR, Golbus MS, Adzick NS, Fily RA,
either by fetal urinalysis or by cordocentesis may be Callen PW, Mahony BS, Anderson RL, De Lorinier AA: Man-
agement of the fetus with congenital hydronephrosis. II: Prognostichelpful.
criteria and selection for treatment. J Pediatr Surg 20:376–387,
1985
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